Todos Medical Ltd. (OTCPK:TOMD.F) exercised the option to acquire the remaining 80.01% stake in Breakthrough Diagnostics Inc. from Amarantus BioScience Holdings, Inc. (OTCPK:AMBS) on April 14, 2019. As a part of consideration, Todos Medical Ltd. will issue ordinary shares to Amarantus BioScience Holdings, Inc. representing 30% of Todos Medical. Upon consummation of the transaction, Amarantus BioScience Holdings will own 49.99% of Todos Medical.

The transaction is subject to shareholders approval of Amarantus BioScience Holdings and Todos Medical Ltd. As of April 29, 2019, shareholders of Todos Medical Ltd. approved the transaction. As of February 25, 2020, the transaction is expected to close in the first half of 2020.